Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01650675 · ClinicalTrials.gov registry record · Phase 2

Indirect Assessment and Intervention for Perinatal Drug Use

A Phase 2 study of Drug Abuse, sponsored by Wayne State University.

Completed
Registry status
Phase 2
Development phase
500
Enrollment target
1
Study location

NCT01650675 is a Phase 2 study of Drug Abuse that has completed, run by Wayne State University. The registered enrollment target is 500 participants, above the 302-participant average among 21 other Drug Abuse trials with a reported enrollment target (66% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01650675, a Phase 2 study of Drug Abuse, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
Phase 2
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the validity of an indirect computer-delivered screener for drug use and assess the efficacy of a computer-delivered brief intervention with urban post-partum women at-risk for substance abuse and HIV during the post-partum period.

Conditions Studied

Interventions

  • BEHAVIORAL WIDUS computer-delivered, indirect brief intervention
  • BEHAVIORAL Nutrition time control/placebo intervention

Study Locations (1)

Michigan

  • Wayne State University - Detroit

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2012-06
Est. Completion 2015-05
Phase Phase 2

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT01650675

The ClinicalTrials.gov registry entry for NCT01650675 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 302-participant average among 21 other Drug Abuse trials with a reported enrollment target (66% higher). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Drug Abuse appearing as the primary indexed condition, and to 2 interventions - of which WIDUS computer-delivered, indirect brief intervention is the first listed.

NCT01650675 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT01650675 about?

NCT01650675 is a clinical study titled "Indirect Assessment and Intervention for Perinatal Drug Use". The purpose of this study is to assess the validity of an indirect computer-delivered screener for drug use and assess the efficacy of a computer-delivered brief intervention with urban post-partum women at-risk for substance abuse and HIV during the post-partum period.

What is the current status of trial NCT01650675?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 500 participants. The study started on 2012-06. Estimated completion is 2015-05.

What conditions does trial NCT01650675 study?

This clinical trial studies the following conditions: Drug Abuse.

What interventions are being tested in trial NCT01650675?

The interventions under investigation include: WIDUS computer-delivered, indirect brief intervention (BEHAVIORAL), Nutrition time control/placebo intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01650675?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01650675 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Drug Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.